Results 261 to 270 of about 156,630 (340)

Cardiovascular Risk Factors in Patients with Valvular Heart Disease: A Nationwide Observational Cohort Study. [PDF]

Int J Gen Med
Lu Q, Lv J, Li Z, Ye Y, Zhang B, Wang W, Zhao Q, Zhang H, Zhao Z, Wang B, Liu Q, Yu Z, Duan Z, Guo S, Zhao Y, Gao R, Xu H, Wu Y, CHINA-VHD collaborators.   +18 more
europepmc   +1 more source

Health at Older Ages: The Causes and Consequences of Declining Disability among the Elderly [PDF]

Dora L. Costa
core  

Feasibility and Safety of Transfemoral Aortic Valve Replacement Using Local Anesthesia in the Catheterization Suite Versus General Anesthesia in the Operation Theater

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background For over a decade, transfemoral transcatheter aortic valve replacements (TF‐TAVR) have been performed at the University Hospital of Nancy. A minimalistic approach to TF‐TAVR, conducted without general anesthesia and entirely percutaneously in a catheterization suite (simplified approach), has been reported to be as safe and ...
Guillaume Abadié, Pierre Adrien Metzdorf, Giuseppe Lauria, Jeanne Varlot, Mazen Elfarra, Florian Eggenspieler, Juan‐Pablo Maureira, Batric Popovic, Edoardo Camenzind   +8 more
wiley   +1 more source

Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Without Mechanical Valves. [PDF]

J Am Heart Assoc
Dawwas GK, Lewis JD, Cuker A.
europepmc   +1 more source

Three‐Cusp View Orientation in TAVI: Evaluating LOA Versus Non‐LOA Impact on Outcomes With Contemporary Valve Prostheses

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Optimal projection views during transcatheter aortic valve implantation (TAVI) procedures are critical for procedural success and patient outcomes. Aims This study investigated the influence of 3‐cusp view orientation—line of alignment (LOA) versus non‐LOA—on procedural outcomes in patients undergoing TAVI with contemporary ...
Rim Kasem Ali Sliman, Amnon Eitan, Keren Zisman, Yuval Avidan, Amir Aker, Hussein Sliman   +5 more
wiley   +1 more source

Pharmacology in Structural Intervention for Valvular Heart Disease: Current Practice and Future Perspectives. [PDF]

Struct Heart
Di Muro FM, Vogel B, Oliva A, Bay B, Gitto M, Dangas GD, Mehran R.   +6 more
europepmc   +1 more source

Electrocardiography: Atrial Fibrillation [PDF]

, 2011
Ginter, James F., Loftis, Patrick
core   +1 more source

Cardiac angiotensin converting enzyme activity and ACE gen polymorphism in patients with chronic valvular disease Cornelia Piper, O. Costerousse, M. Schmidt, Dieter Horstkotte. Heart Center North Rhine-Westphalia, Bad Oeynhausen, Germany

, 2001

openalex   +1 more source

Lessons Learned From the ACURATE IDE Trial for Transcatheter Aortic Valve Replacement

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT The recent voluntary withdrawal of the ACURATE neo2 transcatheter aortic valve replacement device by Boston Scientific offers a compelling case study in the complex interplay of device design, clinical evidence, regulatory requirements, and market dynamics in modern structural heart interventions.
Arturo Giordano, Giuseppe Biondi‐Zoccai, David J. Cohen, Rodrigo Bagur, Nicola Corcione   +4 more
wiley   +1 more source

Physical Frailty and the Risk of Degenerative Valvular Heart Disease. [PDF]

Innov Aging
Guo X, Li Z, Long T, Cheng S, Yang C, Jiang C, Ma H, Gao R, Song C, Huang X, Wu Y.   +10 more
europepmc   +1 more source